CLINICAL_TRIALS
trial_result
· 2026-01-08
Clinical Trial Update: Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas [Phase 1]
Summary
Phase 1 trial update evaluating the safety of UF-KURE19 Cells in Non-Hodgkin lymphoma; the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: David Wald | Conditions: Non Hodgkin Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING